GILEAD SCIENCES INC

GILEAD SCIENCES INC

Displaying 10 out of 2 results

  1. FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, C

    Gilead to buy 49.9per cent stake in cancer drug developer Pionyr for US$275 million

    Gilead Sciences Inc said on Tuesday it would buy a 49.9per cent stake in privately held cancer immunotherapies developer Pionyr Immunotherapeutics ...
  2. FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, C

    Gilead's NASH combination treatment fails main goal of mid-stage study

    Gilead Sciences Inc said on Monday all combinations of its three drugs to treat non-alcoholic steatohepatitis (NASH)failed to meet the main goal ...